Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia

被引：0
|
作者：
Ben-Hamadi, R
Duh, MS
Aggarwal, J
Henckler, A
McKenzie, S
Fastenau, J
Piech, CT
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Ortho Biotech Clin Affairs LLC, Dallas, TX USA
[3] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62574-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [31] A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
    Schwartzberg, L
    Shiffman, R
    Tomita, D
    Stolshek, B
    Rossi, G
    Adamson, R
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2781 - 2796
  • [32] Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis
    Borget, I
    Tilleul, P
    Baud, M
    Joly, AC
    Daguenel, A
    Chouaid, C
    LUNG CANCER, 2006, 51 (03) : 369 - 376
  • [33] Guidelines for using darbepoetin alfa in patients with chemotherapy-induced anemia
    Bloomfield, M
    Jaresko, G
    Zarek, J
    Dozier, N
    PHARMACOTHERAPY, 2003, 23 (12): : 110S - 118S
  • [34] Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis
    Chouaid, C
    Borget, I
    Baud, M
    Joly, AC
    Daguenel, A
    Tilleul, P
    LUNG CANCER, 2005, 49 : S23 - S23
  • [35] Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis
    Borget, Isabelle
    Tilleul, P.
    Baud, M.
    Joly, A. C.
    Chouaid, C.
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 454 - 454
  • [36] A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia
    Kotasek, Dusan
    Canon, Jean-Luc
    Mateos, Maria Victoria
    Hedenus, Michael
    Rossi, Greg
    Taylor, Kerry
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (06) : 1387 - 1401
  • [37] Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia
    Bustos, Aurelia
    Alvarez, Ruth
    Miguel Aramburo, Pedro
    Carabantes, Francisco
    Diaz, Nieves
    Florian, Jesus
    Lazaro, Martin
    Maria Martin de Segovia, Jose
    Antonio Gasquet, Jose
    Alegre, Adrian
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) : 57 - 67
  • [38] Darbepoetin alfa is cost effective compared to epoetin alfa for treatment of anemia in cancer patients receiving chemotherapy.
    Glaspy, JA
    Tchekmedyian, NS
    Gupta, S
    BLOOD, 2002, 100 (11) : 874A - 875A
  • [39] Effectiveness Of Biosimilar Epoetin Alfa For The Treatment Of Chemotherapy-Induced Anemia In Patients With Hematological Malignancies
    Agrawal, Samir G.
    Guy, Andrea
    O'Flaherty, Patricia
    Turner, Matthew
    BLOOD, 2013, 122 (21)
  • [40] Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced AnaemiaEvidence from a 16-Week Randomised Trial
    Shelby D. Reed
    Jasmina I. Radeva
    Davey B. Daniel
    Samir H. Mody
    Jamie B. Forlenza
    R. Scott McKenzie
    Kevin A. Schulman
    PharmacoEconomics, 2006, 24 : 479 - 494
12345